[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352349-105":59,"doc-detail-352349-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","slc46a1-deficiency-mediated-folate-restriction-suppresses-colorectal-cancer-progression-through-epigenetic-transcriptional-reprogramming","SLC46A1 deficiency-mediated folate restriction suppresses colorectal cancer progression through epigenetic transcriptional reprogramming","","Colorectal cancer progression is linked to metabolic reprogramming, yet the molecular drivers of folate-related effects remain unclear. This study reports that folate has a tumor-suppressive role in CRC, but its impact depends on the expression level of the folate transporter SLC46A1. Multi-cohort profiling shows SLC46A1 downregulation predicts poor survival. Mechanistically, SLC46A1 loss limits intracellular folate, reduces methylation capacity, induces DNA hypomethylation, and activates oncogenic transcriptional programs.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/slc46a1-deficiency-mediated-folate-restriction-suppresses-colorectal-cancer-progression-through-epigenetic-transcriptional-reprogramming/352349/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/slc46a1-deficiency-mediated-folate-restriction-suppresses-colorectal-cancer-progression-through-epigenetic-transcriptional-reprogramming/352349.png","ImageObject",300,407,{"name":92,"@type":93},"Aria","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-09","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the central finding about folate and SLC46A1 in colorectal cancer?","Question",{"text":112,"@type":113},"Folate suppresses colorectal cancer progression, but this effect is restricted by the expression level of the folate transporter SLC46A1 in CRC cells.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does reduced SLC46A1 affect cellular methylation and epigenetic status?",{"text":117,"@type":113},"SLC46A1 deficiency limits intracellular folate availability and impairs methylation potential, lowering the SAM/SAH ratio and causing DNA hypomethylation at specific sites such as the FOS promoter.",{"name":119,"@type":110,"acceptedAnswer":120},"What downstream gene activation is linked to the epigenetic transcriptional reprogramming?",{"text":121,"@type":113},"Epigenetic reprogramming triggers transcriptional activation of oncogenic effectors CCND1, BCL2, and PLAU that contribute to CRC progression.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352349,1791183167,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \nSLC46A1 deﬁciency-mediated folate restriction suppresses colorectal cancer progression through epigenetictranscriptional reprogramming  \nYelu Zhou1,5, Yanxing Liu1,5, Yi Liu2,5, Chang Che1, Yihan Zhao 1, Jianing Yu1, Xinhang Li1, Ang Li1, Shuyi Chen 1, Haojia Wang1, Mingzhen Zhou1, Dan Liu 1, Wenfang He1, Zhuo Wang 1, Hua Han 1,3, Xin Wang 1,4, Yuanyuan Lu 1 ✉, Kaichun Wu1 ✉ and Xiaodi Zhao 1 ✉  \n© The Author(s) 2026  \n\n| | The association between folate metabolism abnormalities and the development of colorectal cancer (CRC) remains controversial. Here, we report that the folate exerts a tumor-suppressive role in CRC; however, the manifestation of this effect is restricted by the expression level of folate transporter SLC46A1 in CRC cells. Multi-cohort proﬁling revealed signiﬁcant downregulation of SLC46A1 in CRC tissues compared to adjacent normal tissues, where low expression independently predicted poor overall survival. Functional studies demonstrated that SLC46A1-mediated folate uptake suppressed tumor proliferation, migration, and invasion both in vitro and in vivo. Mechanistically, SLC46A1 deﬁciency restricted intracellular folate availability and impaired cellular methylation potential, as evidenced by a reduced SAM/SAH ratio, leading to DNA hypomethylation at speciﬁc sites such as the FOS protooncogene promoter. This epigenetic reprogramming triggers transcriptional activation of key oncogenic effectors CCND1, BCL2, and PLAU involved in CRC progression. Clinically, we found a signiﬁcant inverse correlation between SLC46A1 expression and folate levels in tumor interstitial ﬂuids of CRC, suggesting impaired folate uptake in low SLC46A1 tumors. Multi-color immunoﬂuorescenceacross two cohorts further demonstrated conserved inverse associations between SLC46A1 and FOS expression in primary tumorsand metastatic lesions. This study elucidates the molecular mechanism by which folate inhibits CRC progression through the“SLC46A1-epigenetic-transcriptional regulation” axis, providing mechanistic insights into folate deﬁciency-driven CRC progression | |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  | and biomarkers for precision CRC intervention. |  |\n|  |  |  |\n|  |  |  |\n|  | Cell Death and Disease (2026)17:189; [https://doi.org/10.1038/s41419-026-08423-8](https://doi.org/10.1038/s41419-026-08423-8) |  |\n|  |  |  |\n\nINTRODUCTION  \nColorectal cancer (CRC) remains a leading cause of cancer-related mortality globally [1, 2] with metabolic reprogramming emerging as a hallmark of its progression. Malignant cells meet their varying demands for metabolites by modulating the transport of these substances [3, 4] and the activity of key enzymes within metabolic cycles [5, 6] . This metabolic manipulation facilitates malignant progression, including tumor proliferation, invasion, metastasis, drug resistance, and angiogenesis [7–9] . Despite these effects, the precise molecular mechanisms that initiate and sustain these metabolic shifts and their role in CRC development are not yet completely understood.  \nFolate-mediated one-carbon metabolism is crucial for cellular processes, including nucleotide synthesis for cell division and the maintenance of methylation balance, which is essential for gene expression and genomic stability [10, 11]. Paradoxically, epidemiological studies present conﬂicting evidence: while folate deﬁciency  \nincreases CRC risk, excessive folate supplementation may paradoxically accelerate tumorigenesis in established lesions. Some malignant cells rely on excess folate metabolism to fulﬁll their biosynthetic needs, which has prompted the development of inhibitors like methotrexate and pralatrexate that have shown efﬁcacy in treating hematological cancers [12, 13]. However, elevated folate metabolism is not observed in all tumor types. Evid","cbCaicga6QwiPycW","https://ap.wps.com/l/cbCaicga6QwiPycW","pdf",17633024,15,"English","# Introduction\n## Folate and one-carbon metabolism in CRC\n## Transporters and metabolic regulation\n## Study rationale and objectives\n# Results\n## SLC46A1 expression and prognosis\n## Functional effects of SLC46A1-mediated folate uptake\n## Mechanistic link to methylation and DNA hypomethylation\n## Clinical and biomarker correlations","[{\"question\":\"What is the central finding about folate and SLC46A1 in colorectal cancer?\",\"answer\":\"Folate suppresses colorectal cancer progression, but this effect is restricted by the expression level of the folate transporter SLC46A1 in CRC cells.\"},{\"question\":\"How does reduced SLC46A1 affect cellular methylation and epigenetic status?\",\"answer\":\"SLC46A1 deficiency limits intracellular folate availability and impairs methylation potential, lowering the SAM/SAH ratio and causing DNA hypomethylation at specific sites such as the FOS promoter.\"},{\"question\":\"What downstream gene activation is linked to the epigenetic transcriptional reprogramming?\",\"answer\":\"Epigenetic reprogramming triggers transcriptional activation of oncogenic effectors CCND1, BCL2, and PLAU that contribute to CRC progression.\"}]","SLC46A1 deficiency-mediated folate restriction suppresses colorectal cancer progression through epigenetic transcriptional reprogramming | PDF",1790099125,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bd1cc385cdda0793ad8302bd86e4bba5.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1421e2d0d4d0833684f1687ea7078009.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2014bf2a997f2a780d46402dec78bedd.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/07f63cf30b73e46ac118071c5088a27d.webp",980,1301]